Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 7 - Number 3







Targeting JAK3 and BTK Tyrosine Kinases with Rationally-Designed Inhibitors

, 7(3): 327 - 343

Alexei O. Vassilev, Heather E. Tibbles, Darin DuMez, Taracad K. Venkatachalam and Fatih M. Uckun


DOI: 10.2174/138945006776054997




Clinical Aspects of Natural Anti-Angiogenic Drugs

, 7(3): 371 - 383

C. P. Neal, D. P. Berry, H. Doucas, M. M. Manson, W. Steward and G. Garcea


DOI: 10.2174/138945006776054951



Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

webinar-July-21

Related Journals

Related eBooks

eBooks Catalog